Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
A wide range of studies have been published over the past two decades that involve the intersection of sleep EEG, insomnia, psychiatric illness (especially depressive disorders) and psychopharmacology. Much of value has been discovered, but there have also been false starts and contradictory results. There is in fact strong evidence that insomnia is associated with medical and psychiatric illness and that the sleepiness associated with insomnia is the cause of many accidents. Thus, the direct (visits to doctors, cost of sleeping medication, complications from use of these medications) and indirect (accidents, quality of life) costs of insomnia are enormous and constitute a major public health problem in the industrialized countries. Believing that it is now timely to assess the state of this important research area, a consensus conference was convened on June 26–28, 1998, in Porto Cervo (Italy) to attempt to clarify the important issues and findings on the clinical effect of the different classes of antidepressant drugs on sleep quality in depression. The participants’ consensus on some of the main topics is presented with the hope that this discussion and analysis will contribute to productive research in this important field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders: An Opportunity for Prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.1989.03430110069030 · Cited by 2,252
Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults
Breslau, N., Roth, T., Rosenthal, L., & Andreski, P. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00188-3 · Cited by 1,831
Sleep and Psychiatric Disorders: A Meta-analysis
Benca, R. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080059010 · Cited by 1,468
Dijk, D., & Czeisler, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03526.1995 · Cited by 1,356
Mortality Risk Associated with Sleeping Patterns Among Adults
Wingard, D. L., & Berkman, L. F. (1983) · Sleep · doi:10.1093/sleep/6.2.102 · Cited by 371
Schenck, C. H., Mahowald, M. W., Kim, S. W., O'Connor, K. A., & Hurwitz, T. D. (1992) · Sleep · doi:10.1093/sleep/15.3.226 · Cited by 261
Rush, A. J., Armitage, R., Gillin, J. C., Yonkers, K. A., Winokur, A., Moldofsky, H., Vogel, G. W., Kaplita, S. B., Fleming, J. B., Montplaisir, J., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00092-4 · Cited by 215
Self-citationDryman, A., & Eaton, W. W. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb01410.x · Cited by 169
The effects of paroxetine and nefazodone on sleep: a placebo controlled trial
Sharpley, A. L., Williamson, D. J., Attenburrow, M. E. J., Pearson, G., Sargent, P., & Cowen, P. J. (1996) · Psychopharmacology · doi:10.1007/bf02246410 · Cited by 122
Self-citationEffects of trazodone on the sleep of depressed subjects—a polygraphic study
Mouret, J., Lemoine, P., Minuit, M. P., Benkelfat, C., & Renardet, M. (1988) · Psychopharmacology · doi:10.1007/bf00172629 · Cited by 116
Gillin, J. C., Rapaport, M., Erman, M. K., Winokur, A., & Albala, B. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0502 · Cited by 104
Armitage, R., Yonkers, K., Cole, D., & Rush, A. J. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00004 · Cited by 97
Self-citation(1995) · Sleep · doi:10.1093/sleep/18.6.470 · Cited by 90
Self-citationWare, J. C., Brown, F. W., Moorad, P. J., Pittard, J. T., & Cobert, B. (1989) · Sleep · doi:10.1093/sleep/12.6.537 · Cited by 88
Saletu, B., Gr�nberger, J., & Linzmayer, L. (1986) · Journal of Neural Transmission · doi:10.1007/bf01243351 · Cited by 78
Self-citationFluvoxamine versus desipramine: Comparative polysomnographic effects
Kupfer, D. J., Perel, J. M., Pollock, B. G., Nathan, R. S., Grochocinski, V. J., Wilson, M. J., & McEachran, A. B. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90208-4 · Cited by 78
Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients
Shipley, J. E., Kupfer, D. J., Griffin, S. J., Dealy, R. S., Coble, P. A., McEachran, A. B., Grochocinski, V. J., Ulrich, R., & Perel, J. M. (1985) · Psychopharmacology · doi:10.1007/bf00427316 · Cited by 70
Effects of trazodone on EEG sleep and clinical state in major depression
van Bemmel, A. L., Havermans, R. G., & van Diest, R. (1992) · Psychopharmacology · doi:10.1007/bf02245272 · Cited by 67
Fluoxetine in Major Depression: Efficacy, Safety and Effects on Sleep Polygraphic Variables
KERKHOFS, M., RIELAERT, C., MAERTELAER, V. D., LINKOWSKI, P., CZARKA, M., & MENDLEWICZ, J. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199010000-00002 · Cited by 61
Self-citationFluoxetine and Oculomotor Activity during Sleep in Depressed Patients
Armitage, R. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00075-b · Cited by 60
Self-citationThe Effect of Trimipramine on Sleep in Patients with Major Depressive Disorder
Wiegand, M., Berger, M., Zulley, J., & von Zerssen, D. (1986) · Pharmacopsychiatry · doi:10.1055/s-2007-1017193 · Cited by 59
Polysomnographic studies of unmedicated depressed men before and after cognitive behavioral therapy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.11.1615 · Cited by 57
Ware, J. C., Rose, F. V., & McBrayer, R. H. (1994) · Sleep · doi:10.1093/sleep/17.6.544 · Cited by 56
Shipley, J. E., Kupfer, D. J., Dealy, R. S., Griffin, S. J., Coble, P. A., McEachran, A. B., & Grochocinski, V. J. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.171 · Cited by 49
Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?
Vogel, G., Cohen, J., Mullis, D., Kensler, T., & Kaplita, S. (1998) · Sleep · doi:10.1093/sleep/21.1.70 · Cited by 44
Effect of a Reversible Monoamine Oxidase-A Inhibitor (Moclobemide) on Sleep of Depressed Patients
Monti, J. M. (1989) · British Journal of Psychiatry · doi:10.1192/s000712500029750x · Cited by 41
Effects of Antidepressant Treatment on Sleep EEG in Depression
Armitage, R. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601001s01 · Cited by 18
Self-citation
Cited by
The Direct and Indirect Costs of Untreated Insomnia in Adults in the United States
Ozminkowski, R. J., Wang, S., & Walsh, J. K. (2007) · Sleep · doi:10.1093/sleep/30.3.263 · Cited by 403
Internet Gaming Addiction, Problematic Use of the Internet, and Sleep Problems: A Systematic Review
Lam, L. T. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0444-1 · Cited by 394
Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
Abbas, A. I., Hedlund, P. B., Huang, X.-P., Tran, T. B., Meltzer, H. Y., & Roth, B. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1521-8 · Cited by 285
Bright-Light Therapy in the Treatment of Mood Disorders
Pail, G., Huf, W., Pjrek, E., Winkler, D., Willeit, M., Praschak-Rieder, N., & Kasper, S. (2011) · Neuropsychobiology · doi:10.1159/000328950 · Cited by 277
Raison, C. L., Rye, D. B., Woolwine, B. J., Vogt, G. J., Bautista, B. M., Spivey, J. R., & Miller, A. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.019 · Cited by 116
Metadata
- Authors
- Brunello, N., Armitage, R., Feinberg, I., Holsboer-Trachsler, E., Léger, D., Linkowski, P., Mendelson, W. B., Racagni, G., Saletu, B., Sharpley, A. L., Turek, F., van Cauter, E., & Mendlewicz, J.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2000
- Volume
- 42
- Issue
- 3
- Pages
- 107-119
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W1979140166
- Cited by
- 65
- References
- 27
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.